Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting.
about
Blood transfusion medicineRapid and simultaneous detection of human hepatitis B virus and hepatitis C virus antibodies based on a protein chip assay using nano-gold immunological amplification and silver staining method.Genetic variation of occult hepatitis B virus infectionToward giga-pixel nanoscopy on a chip: a computational wide-field look at the nano-scale without the use of lensesPrevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patientsA Novel Diagnostic Target in the Hepatitis C Virus GenomeEvaluation of Hepatitis C Virus Core Antigen Assays in Detecting Recombinant Viral Antigens of Various GenotypesRapid Detection Strategies for the Global Threat of Zika Virus: Current State, New Hypotheses, and LimitationsBats worldwide carry hepatitis E virus-related viruses that form a putative novel genus within the family HepeviridaeOccult infection with hepatitis C virus: friend or foe?A population-based study of human immunodeficiency virus in south India reveals major differences from sentinel surveillance-based estimatesTransfusion of platelet concentrates cryopreserved with ThromboSol plus low-dose dimethylsulphoxide in patients with severe thrombocytopenia: a pilot study.Prevention of transfusion-transmitted cytomegalovirus infection.Blood screening for influenza.Genomic screening for blood-borne viruses in transfusion settings.Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assaysTaqMan 5'-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening.Optimal blood donation screening annotation.Simultaneous visual detection of multiple viral amplicons by dipstick assay.Viral safety of haemophilia treatment products.Detection of hepatitis C virus core antigen for early diagnosis of hepatitis C virus infection in plasma donor in China.Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificitySufficient blood, safe blood: can we have both?Will blood transfusion ever be safe enough?Evaluation of a new combined antigen and antibody human immunodeficiency virus screening assay, VIDAS HIV DUO Ultra.Screening of HIV infection: role of molecular and immunological assays.Nucleic acid amplification technology methods used in blood donor screening.US NAT yield: where are we after 2 years?Occult hepatitis B virus infection and blood transfusionThe present and future of Transfusion MedicineMolecular virology in transfusion medicine laboratory.Capturing and concentrating adenovirus using magnetic anionic nanobeads.Implementation of an HIV-1 Triple-Target NAT Assay in the Routine Screening at Three German Red Cross Blood Centres.Diagnostic algorithm for HBV safe transfusion.Large scale screening of human sera for HCV RNA and GBV-C RNA.Emerging Pathogens - How Safe is Blood?Various on-chip sensors with microfluidics for biological applications.Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe.Efficacy of a hepatitis C virus core antigen enzyme-linked immunosorbent assay for the identification of 'window-phase' blood donations.Capture of dengue viruses using antibody-integrated graphite-encapsulated magnetic beads produced using gas plasma technology.
P2860
Q24527207-C61852C8-DFED-48BD-9520-CE7035BA81EFQ24816487-DB4BE87D-F18A-4E7B-AC23-4E42BC47482EQ26751031-85A3C106-F3BE-433B-ADB0-A67520FC8C0FQ26825691-96ECEF44-87C5-4362-97A1-37D0EBD7B406Q27477958-E4682A5D-8482-47A0-9070-083550D0743AQ27487878-99B84349-A782-46D2-9D57-25161660DCC4Q27490457-14429BFE-1245-429E-BC76-40A43E3ACAA7Q27928011-49D377DF-BA0E-43AF-A65E-9D5003A6B65DQ28728496-FA9A0C06-08C6-4399-BB55-208941FBC167Q30416187-2858395C-3330-4587-B988-8810B74A5F75Q33266456-375B081E-4BEE-452B-B9AD-3B58E95F2A98Q33332057-42A9352E-D8D3-400F-9331-01EC42A9A429Q33650397-BD3CCBCB-A1CA-4E0B-9981-A942B5C8D1E8Q33883993-1A408265-A52A-4A06-B125-844E245A8A94Q33890340-C1891BED-9114-4D5C-9AB2-95308481644FQ33971376-51DC3470-848E-4921-A8C2-548E976F2D7AQ33974221-1CDA09AD-A130-4288-A6BF-A9F4EBCC13B2Q33992800-8BB49F7A-5298-4D49-9DF6-41C305708ADBQ34041871-8FDDEEB6-34F9-41E3-BC12-0B0D64A9BC29Q34087439-5A3B47F2-48CB-46CF-AEFE-055BA4AFF8C9Q34100073-CE8FB5AB-1A2C-4CC6-8E22-D8F5419DFD6EQ34195573-5405E6CE-8565-4381-A47F-F637C7190E97Q34206713-AAE42489-13EE-448B-88AE-4C87C4E04FB0Q34261260-7777514B-CBF7-4E53-9146-E869B2756F17Q34453624-3638BAF7-BB27-437F-B215-C4474083204FQ34527302-0E1084FA-1E41-417C-832F-46286A6E9EC2Q34830170-CA4AEC5F-D929-4C2D-8CD5-9C0A6F51494CQ34830197-15D4786F-60F1-41D5-AB01-3166A69E121AQ35237335-EC00134B-2107-477C-954E-A05649FF58EDQ35434303-9EA2BF69-F017-4AD0-ADD8-A2EB66EDB6EBQ36766449-3B2DC06B-2584-4DB3-B319-569AC2359D42Q36907989-EAF2EC53-A50F-427E-899F-B004EA4015D2Q37045800-7B9A91D0-8263-48E8-BCBF-822680E23C3BQ37284917-60C3BC27-804C-47C3-88EC-317F69DC27B8Q37626109-465D9631-1171-4289-9A63-2B070A6BE204Q37630317-96A621B3-86C8-4238-96FD-2F6C6316E6D9Q38249219-53D6F13A-77B3-471C-9190-C1618F488578Q38454850-B324E89F-F93D-4415-BBE3-21783747F389Q38461450-340DFFE0-652E-4C1E-9469-7944EB5E21D5Q38768747-5C4DF3FB-CA68-44FA-893D-F8AB602F5218
P2860
Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Feasibility and efficacy of ro ...... HIV-1 in a blood-bank setting.
@ast
Feasibility and efficacy of ro ...... HIV-1 in a blood-bank setting.
@en
type
label
Feasibility and efficacy of ro ...... HIV-1 in a blood-bank setting.
@ast
Feasibility and efficacy of ro ...... HIV-1 in a blood-bank setting.
@en
prefLabel
Feasibility and efficacy of ro ...... HIV-1 in a blood-bank setting.
@ast
Feasibility and efficacy of ro ...... HIV-1 in a blood-bank setting.
@en
P2093
P1433
P1476
Feasibility and efficacy of ro ...... HIV-1 in a blood-bank setting.
@en
P2093
P304
P356
10.1016/S0140-6736(98)06318-1
P407
P577
1999-01-01T00:00:00Z